Lexaria Bioscience Ownership | Who Owns Lexaria Bioscience?


OverviewRevenueFinancialsChart

Lexaria Bioscience Ownership Summary


Lexaria Bioscience is owned by 1.77% institutional investors, 5.74% insiders, and 92.49% retail investors. Murchinson is the largest institutional shareholder, holding 2.29% of LEXX shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.20% of its assets in Lexaria Bioscience shares.

LEXX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLexaria Bioscience1.77%5.74%92.49%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Murchinson419.59K2.29%$399.74K
Invenomic capital management lp442.30K1.81%$345.00K
Vanguard group258.82K1.21%$159.69K
Geode capital management294.16K1.20%$229.47K
Toronto dominion bank140.01K0.57%$109.28K
Vanguard fiduciary trust94.17K0.39%$73.45K
Raymond james financial services advisors48.80K0.35%$135.66K
Ubs group52.71K0.22%$41.11K
Blackrock27.45K0.20%$76.30K
State street39.30K0.16%$30.66K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Murchinson419.59K0.05%$399.74K
Invenomic capital management lp442.30K0.02%$345.00K
Virtu financial29.36K0.00%$28.00K
Krilogy financial19.65K0.00%$19.36K
Byrne asset management800.000.00%$624.00
Xtx topco25.07K0.00%$19.55K
Raymond james financial services advisors48.80K0.00%$135.66K
Toronto dominion bank140.01K0.00%$109.28K
Vontobel23.00K0.00%$17.94K
Federation des caisses desjardins du quebec382.00-$298.00

Top Buyers

HolderShares% AssetsChange
Murchinson419.59K0.05%419.59K
Vanguard fiduciary trust94.17K-94.17K
Geode capital management294.16K-74.44K
Virtu financial29.36K0.00%29.36K
Blackrock27.45K-25.94K

Top Sellers

HolderShares% AssetsChange
Sabby management---1.17M
Armistice capital---460.00K
Ubs group52.71K--308.59K
Byrne asset management800.000.00%-104.70K
Raymond james financial---61.25K

New Positions

HolderShares% AssetsChangeValue
Murchinson419.59K0.05%419.59K$399.74K
Vanguard fiduciary trust94.17K-94.17K$73.45K
Virtu financial29.36K0.00%29.36K$28.00K
Xtx topco25.07K0.00%25.07K$19.55K
Vontobel23.00K0.00%23.00K$17.94K

Sold Out

HolderChange
Pnc financial services group-6.00
Northwestern mutual wealth management-9.00
Sound income strategies-22.00
Allworth financial lp-89.00
Mather group, llc.-100.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202612-42.86%433,493-74.52%12.80%7-22.22%2-
Dec 31, 202514-44.00%1,062,180-38.15%45.64%7-46.15%--100.00%
Sep 30, 20252519.05%1,717,330-25.25%95.95%1344.44%2-
Jun 30, 202521-4.55%2,297,06385.28%1225.05%8-20.00%3-25.00%
Mar 31, 20251-96.00%549,947-61.85%34.20%1-92.31%--100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr298.44K1.20%76.14K
Invenomic Institutional196.51K0.79%-26.26K
Fidelity Extended Market Index172.52K0.70%49.90K
BlackRock Extended Equity Market K22.61K0.14%-10.00
Spartan Extended Market Index Pool F35.45K0.14%13.96K
Fidelity Series Total Market Index31.89K0.13%4.74K
Fidelity Total Market Index26.14K0.11%-
Blackrock Extended Mkt Fund CF25.94K0.10%-
Extended Equity Market Fund B25.94K0.10%-
Extended Equity Market Fund E25.94K0.10%-

Recent Insider Transactions


DateNameRoleActivityValue
Jul 30, 2025BUNKA CHRISTOPHER-Buy$10.87K
Jul 29, 2025BUNKA CHRISTOPHER-Buy$14.38K
Jul 29, 2025McKechnie William Edward-Buy$4.53K
Jul 29, 2025DOCHERTY JOHN MARTIN President & CSOBuy$4.99K
Jul 29, 2025Carle Vanessa SecretaryBuy$682.50

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q36-
2025 Q2--
2025 Q1--
2024 Q311

LEXX Ownership FAQ


Who Owns Lexaria Bioscience?

Lexaria Bioscience shareholders are primarily institutional investors at 1.77%, followed by 5.74% insiders and 92.49% retail investors. The average institutional ownership in Lexaria Bioscience's industry, Biotech Stocks , is 35.75%, which Lexaria Bioscience falls below.

Who owns the most shares of Lexaria Bioscience?

Lexaria Bioscience’s largest shareholders are Murchinson (419.59K shares, 2.29%), Invenomic capital management lp (442.3K shares, 1.81%), and Vanguard group (258.82K shares, 1.21%). Together, they hold 5.31% of Lexaria Bioscience’s total shares outstanding.

Does Blackrock own Lexaria Bioscience?

Yes, BlackRock owns 0.20% of Lexaria Bioscience, totaling 27.44K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 76.3K$. In the last quarter, BlackRock increased its holdings by 25.94K shares, a 1719.96% change.

Who is Lexaria Bioscience’s biggest shareholder by percentage of total assets invested?

Murchinson is Lexaria Bioscience’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 419.59K Lexaria Bioscience shares, valued at 399.74K$.

Who is the top mutual fund holder of Lexaria Bioscience shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Lexaria Bioscience shares, with 1.20% of its total shares outstanding invested in 298.44K Lexaria Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools